Advanced airway management in out of hospital cardiac arrest: A Systematic Review and Meta-Analysis

Ruan Vlok

Importance

Currently there is no clear evidence as to which advanced airway device should be used during an out-of-hospital cardiac arrest (OHCA).To assess the difference in survival and neurological outcomes between endotracheal tube (ETT) intubation and supraglottic airway (SGA) devices used during OHCA.

Data Sources

A systematic search of five databases was performed by two independent reviewers until June 2018.

Study Selection

Included studies reported on (1) OHCA or cardiopulmonary resuscitation, and (2) endotracheal intubation versus supraglottic airway device intubation. Exclusion criteria (1) stimulation studies, (2) selectively included/excluded  patients, (3) in-hospital cardiac arrest.

Main Outcomes and Measures

Primary outcomes (1) return of spontaneous circulation (ROSC), (2) survival to hospital admission, (3) survival to hospital discharge, (4) discharge with a neurologically intact state.

Results

Twenty-six studies (n=526,642) showed that overall, ETT use resulted in a heterogenous, but significant increase in ROSC (OR=1.52; 95% CI=1.35 to 1.71; I2=88%;  p<0.00001) and survival to admission (OR=1.45; 95%CI=1.17 to 1.78; I2=90%; p=0.0006). There was no significant difference in survival to discharge or neurological outcome(p=0.10).  On sensitivity analysis of RCTs, without heterogeneity, there was no significant difference in ROSC (I2=0%; p=0.59) or survival to admission (I2=0%; p=0.99).  On analysis of automated chest compression, without heterogeneity, ETT provided a significant increase in ROSC (OR=1.55; 95%CI=1.20 to 2.00; I2=0%; p=0.0009) and survival to admission (OR=2.16; 95%CI=1.54 to 3.02; I2=0%;  p<0.00001).

Conclusions and Relevance

The overall heterogenous benefit in survival with ETT was not replicated in the low risk RCTs, with no significant difference in ROSC or survival to admission.  In the presence of automated chest compressions, ETT intubation may result in survival benefits.

November, 2020
10.37912/WaggaJOM.0201.17

Subscribe to our newsletter

Latest Articles

December, 2024
Cost-Effective Analysis of Inflammatory Bowel Disease Models of Care, A Rural Perspective
Dr Thomas Skinner, BSci, M.D. Dr Symret Singh, BCom M.D. , Dr Nishmi Gunasingam Introduction Unlike many chronic conditions, Inflammatory Bowel Disease (IBD) are often...
December, 2024
Can artificial intelligence play a role in the analysis of non-gated, non-cardiac CT?
Jack Evans, Professor Joseph Suttie Abstract The rapid development of artificial intelligence (AI) has offered an opportunity to improve processing time and diagnostic accuracy of radiological images (1). Deep...
December, 2024
Asthma Morbidity and its Association with Socioeconomic Status in the Australian Population
Dr. Matin Zohoori Niya, Dr. Joanne Hart, Dr. Rajneesh Kaur Background Asthma Australia reports that prevalence of asthma is highest among people living in the lowest socioeconomic areas. Studies...
December, 2024
The Many Fronts of Heart Failure Monitoring – An Observational Study into Heart Failure Patients using Right Heart Catheterisation and Pulse Wave Analysis
Billy Poulden, Dr Audrey Adji, Professor Christopher Hayward Introduction Heart failure (HF) is a condition that occurs when a person’s heart is unable to pump enough blood to adequately...
December, 2024
Outcomes of Telepsychiatry in Australia, a clinical review
Helen Devery and Peter Sheeran Introduction Use of telephone and videoconferencing technologies by psychiatrists is a frequently proposed solution to address lack of resourcing and staff shortages in regional...